The Hollings Cancer Center (HCC) seeks to reduce the cancer burden in its catchment area: the state of South Carolina (SC). The distinct characteristics of SC?s cancer burden informs HCC investigators on priority empha- sis areas for basic, clinical, and population sciences research, including on ethnic, sociocultural, geographic, and other factors influencing disparities that merit increased attention and intervention. HCC?s ongoing assess- ment of its catchment area also guides the center?s community-focused and evidence-based education, cancer screening services, and public policy advocacy efforts. Although the city of Charleston, the home of the HCC, lies on the eastern seaboard of SC, HCC?s outreach efforts over more than two decades have reached every county of the state. As in the rest of the US, breast, colorectal, lung, and prostate cancer account for most newly diagnosed cancer cases and cancer-related deaths; but there is an excess burden of these and other cancers among African Americans. HCC members in the four research programs are committed to serving the state by identifying mechanisms that account for the variability in cancer health outcomes, and ensuring that SC?s diversity is reflected in, and addressed by, HCC-based research. To this end, HCC has invested signifi- cantly in establishing institutional and community-based infrastructure to facilitate community engagement. The HCC has supported a centralized Community Outreach & Engagement (COE) Office since 2007. COE efforts provide evidence-based cancer screenings via a mobile health unit to more than 19 SC counties, lay naviga- tion for medically underserved individuals newly diagnosed with cancer, diverse educational forums supported by dedicated Community Health Educators, and an organizational focal point for HCC?s statewide, cancer-fo- cused advocacy and public policy efforts. The COE Office is also supported by a Cancer Disparities Advisory Committee, comprising community stakeholders from around the state. Guided by this committee?s input, the COE Office participated in or directed more than 850 community engagements throughout the catchment area during the past five years. These efforts reached nearly 13,000 diverse individuals with culturally-tailored edu- cation about cancer, cancer risks, cancer screening, and benefits of clinical trial participation. The COE Office supports cancer disparities-focused research in part through new awards that include: 1) an NCI U54 Cancer Disparities Research Center in collaboration with SC State University; 2) an NIMHD U54 Transdisciplinary Col- laboration Center that applies precision medicine to address prostate cancer disparities; and 3) the NCI Com- munity Oncology Research Program, which effectively extends trial options to minority and rural communities. While HCC has always been invested in community outreach and engagement, this new formal section in the CCSG will help HCC dedicate the additional emphasis and support required to make major strides in better serving the entire catchment area of South Carolina.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA138313-12
Application #
9926249
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
12
Fiscal Year
2020
Total Cost
Indirect Cost
Name
Medical University of South Carolina
Department
Type
DUNS #
183710748
City
Charleston
State
SC
Country
United States
Zip Code
29407
Wrangle, John M; Velcheti, Vamsidhar; Patel, Manish R et al. (2018) ALT-803, an IL-15 superagonist, in combination with nivolumab in patients with metastatic non-small cell lung cancer: a non-randomised, open-label, phase 1b trial. Lancet Oncol 19:694-704
Panneer Selvam, Shanmugam; Roth, Braden M; Nganga, Rose et al. (2018) Balance between senescence and apoptosis is regulated by telomere damage-induced association between p16 and caspase-3. J Biol Chem 293:9784-9800
Janakiraman, Harinarayanan; House, Reniqua P; Gangaraju, Vamsi K et al. (2018) The Long (lncRNA) and Short (miRNA) of It: TGF?-Mediated Control of RNA-Binding Proteins and Noncoding RNAs. Mol Cancer Res 16:567-579
Jin, Junfei; Lu, Zhongyang; Li, Yanchun et al. (2018) LPS and palmitate synergistically stimulate sphingosine kinase 1 and increase sphingosine 1 phosphate in RAW264.7 macrophages. J Leukoc Biol 104:843-853
Joseph, Anne M; Rothman, Alexander J; Almirall, Daniel et al. (2018) Lung Cancer Screening and Smoking Cessation Clinical Trials. SCALE (Smoking Cessation within the Context of Lung Cancer Screening) Collaboration. Am J Respir Crit Care Med 197:172-182
Rojewski, Alana M; Tanner, Nichole T; Dai, Lin et al. (2018) Tobacco Dependence Predicts Higher Lung Cancer and Mortality Rates and Lower Rates of Smoking Cessation in the National Lung Screening Trial. Chest 154:110-118
Ramshesh, Venkat K; Lemasters, John J (2018) Imaging of Mitochondrial pH Using SNARF-1. Methods Mol Biol 1782:351-356
Kim, Myung Jong; Jeon, Sohee; Burbulla, Lena F et al. (2018) Acid ceramidase inhibition ameliorates ?-synuclein accumulation upon loss of GBA1 function. Hum Mol Genet 27:1972-1988
Chatterjee, Shilpak; Chakraborty, Paramita; Daenthanasanmak, Anusara et al. (2018) Targeting PIM Kinase with PD1 inhibition Improves Immunotherapeutic Antitumor T-cell Response. Clin Cancer Res :
Jiang, Yu Lin; Zhu, Yun; Moore, Alfred B et al. (2018) Biotinylated Bioluminescent Probe for Long Lasting Targeted in Vivo Imaging of Xenografted Brain Tumors in Mice. ACS Chem Neurosci 9:100-106

Showing the most recent 10 out of 536 publications